PMV Pharmaceuticals (PMVP) to Release Quarterly Earnings on Thursday

PMV Pharmaceuticals (NASDAQ:PMVP) is anticipated to announce its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of ($0.38) per share for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 14, 2026 at 9:30 AM ET.

PMV Pharmaceuticals (NASDAQ:PMVP) last announced its quarterly earnings results on Tuesday, May 12th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.07. On average, analysts expect PMV Pharmaceuticals to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

PMV Pharmaceuticals Stock Performance

Shares of PMVP stock opened at $1.12 on Tuesday. PMV Pharmaceuticals has a 52-week low of $1.02 and a 52-week high of $1.88. The stock has a market cap of $59.73 million, a price-to-earnings ratio of -0.75 and a beta of 1.34. The firm has a fifty day moving average of $1.20 and a 200-day moving average of $1.27.

Hedge Funds Weigh In On PMV Pharmaceuticals

Institutional investors have recently added to or reduced their stakes in the company. Boothbay Fund Management LLC acquired a new position in shares of PMV Pharmaceuticals in the 3rd quarter valued at $282,000. Bridgeway Capital Management LLC increased its holdings in PMV Pharmaceuticals by 115.5% in the third quarter. Bridgeway Capital Management LLC now owns 320,653 shares of the company’s stock valued at $449,000 after purchasing an additional 171,853 shares during the last quarter. Tang Capital Management LLC lifted its stake in PMV Pharmaceuticals by 3.2% in the fourth quarter. Tang Capital Management LLC now owns 4,940,000 shares of the company’s stock valued at $6,175,000 after buying an additional 154,799 shares during the period. Bank of America Corp DE lifted its stake in PMV Pharmaceuticals by 457.5% in the third quarter. Bank of America Corp DE now owns 162,496 shares of the company’s stock valued at $227,000 after buying an additional 133,349 shares during the period. Finally, Jane Street Group LLC lifted its stake in PMV Pharmaceuticals by 30.5% in the fourth quarter. Jane Street Group LLC now owns 498,641 shares of the company’s stock valued at $623,000 after buying an additional 116,591 shares during the period. 90.20% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Weiss Ratings lowered shares of PMV Pharmaceuticals from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, July 28th. Oppenheimer dropped their price target on shares of PMV Pharmaceuticals from $6.00 to $5.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Evercore upgraded shares of PMV Pharmaceuticals to a “strong-buy” rating in a research note on Monday, April 13th. Finally, LADENBURG THALM/SH SH began coverage on PMV Pharmaceuticals in a report on Wednesday, July 8th. They set a “buy” rating and a $3.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, PMV Pharmaceuticals presently has a consensus rating of “Moderate Buy” and an average target price of $4.00.

PMV Pharmaceuticals Company Profile

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc and changed its name to PMV Pharmaceuticals, Inc in July 2013. PMV Pharmaceuticals, Inc was incorporated in 2013 and is based in Princeton, New Jersey.